Cargando...
Clinical effectiveness of dolutegravir in the treatment of HIV/AIDS
Dolutegravir (DTG) is a second-generation integrase strand transfer inhibitor (INSTI), which has now been licensed to be used in different countries including the UK. Earlier studies have demonstrated that DTG when used with nucleoside backbone in treatment-naïve and - experienced patients has been...
Guardado en:
| Publicado en: | Infect Drug Resist |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Dove Medical Press
2015
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4598225/ https://ncbi.nlm.nih.gov/pubmed/26491363 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IDR.S68396 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|